Telecom Healthcare Sector

Creo Medical Group

Market Cap: UK£40.8m

Through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments in the United Kingdom.

Apyx Medical

Market Cap: US$54.0m

An energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally.

Hydreight Technologies

Market Cap: CA$75.4m

Provides mobile health and wellness services primarily in the United States.

Ikena Oncology

Market Cap: US$53.6m

An oncology company, focuses on developing therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance.

Fortress Biotech

Market Cap: US$53.5m

A biopharmaceutical company, engages in the development and commercialization of biopharmaceutical products.

Odonate

Market Cap: US$53.3m

A pharmaceutical company, develops therapeutics for the treatment of cancer.

America Great Health

Market Cap: US$53.0m

Operates as a biotechnology company in the United States.

Shattuck Labs

Market Cap: US$52.7m

A biotechnology company, develops antibodies for the treatment of inflammatory and immune-mediated diseases.

HeartBeam

Market Cap: US$52.3m

Operates as a medical technology company that focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting.

Actinium Pharmaceuticals

Market Cap: US$52.1m

Develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies.

Artrya

Market Cap: AU$81.3m

A medical technology company, engages in the development and commercialisation of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia.

Beamtree Holdings

Market Cap: AU$81.1m

Provides artificial intelligence-based decision support software and data insight services to healthcare industry in Australia and internationally.

Immuneering

Market Cap: US$51.8m

A clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients.

Covalon Technologies

Market Cap: CA$72.4m

Engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally.

Forte Biosciences

Market Cap: US$51.7m

Operates as a clinical-stage biopharmaceutical company in the United States.

Akoya Biosciences

Market Cap: US$51.4m

A life sciences technology company, provides spatial biology solutions for transforming discovery, clinical research, and diagnostics in North America, the Asia-Pacific, Europe, the Middle East, and Africa.

Beroni Group

Market Cap: AU$75.9m

Develops and sells smoking control products, air purifiers, water filters, cosmetics, stem-cell therapies, and health care products and supplements in Australia and internationally.

PepGen

Market Cap: US$50.4m

A clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States.

OKYO Pharma

Market Cap: US$50.2m

A clinical-stage biopharmaceutical company, develops therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom.

Earth Science Tech

Market Cap: US$50.0m

Focuses on health and wellness industry.

Prelude Therapeutics

Market Cap: US$49.9m

A clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients.

Werewolf Therapeutics

Market Cap: US$49.8m

A biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer.

PainChek

Market Cap: AU$77.4m

Develops and commercialized mobile medical device applications that provides pain assessment for individuals in Australia, the United Kingdom, and internationally.

Artiva Biotherapeutics

Market Cap: US$49.5m

A clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers.

Precision BioSciences

Market Cap: US$49.4m

A clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States.

OpGen

Market Cap: US$49.3m

A precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally.

SafeSpace Global

Market Cap: US$49.2m

Through its subsidiaries, develops healthcare technology solutions to enhance safety and streamline operations in hospitals, schools, transportation hubs, and industrial sites in the United States.

Armata Pharmaceuticals

Market Cap: US$48.8m

Operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide.

bluebird bio

Market Cap: US$48.7m

A biotechnology company, researches, develops, and commercializes gene therapies for curative severe genetic diseases in the United States.

Rein Therapeutics

Market Cap: US$48.6m

A biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications in the United States.

Ondine Biomedical

Market Cap: UK£36.6m

A life-sciences company, engages in the development and commercialization of treat infections, including those caused by drug-resistant pathogens antimicrobial therapies in Canada and internationally.

Hyperfine

Market Cap: US$48.4m

A health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products.

Century Therapeutics

Market Cap: US$48.2m

A clinical-stage biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune diseases.

EZZ Life Science Holdings

Market Cap: AU$75.2m

Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally.

HST Global

Market Cap: US$48.0m

Operates as an integrated health and wellness biotechnology company in the United States.

Zomedica

Market Cap: US$47.5m

A veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals.